Edition:
United Kingdom

People: Shin Nippon Biomedical Laboratories Ltd (2395.T)

2395.T on Tokyo Stock Exchange

767JPY
7:00am BST
Change (% chg)

¥1 (+0.13%)
Prev Close
¥766
Open
¥759
Day's High
¥776
Day's Low
¥743
Volume
533,100
Avg. Vol
565,833
52-wk High
¥980
52-wk Low
¥442

Yamakawa, Takeshi 

Mr. Takeshi Yamakawa has been serving as Director in SHIN NIPPON BIOMEDICAL LABORATORIES, LTD, as well as Chief Executive Officer in a subsidiary SNBL Clinical Pharmacy Center,Inc., since June 2011. He is also Vice Chairman of another subsidiary, SNBL U.S.A.,Ltd. He joined the Company in October 2010. His previous titles include Executive Officer and Managing Executive Officer. Mr. Yamakawa used to work for Ministry of Internal Affairs and Communications, as well as Ministry of Foreign Affairs of Japan.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --